# Sascha Berger

> Sascha Berger is a Series A investor at TVM Capital Life Science backing Health Care and Wellness. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [TVM Capital Life Science](https://shizune.co/investors/profile/tvm-capital-life-science)
- Location: Munich, Germany
- Total investments: 3
- Last investment: Mar 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sasber/
- X (Twitter): https://twitter.com/MrBergerVC

Sascha Berger is a Series A investor at TVM Capital Life Science in Munich focused on Health Care and Wellness. Sascha Berger joined the TVM Capital Life Science team, Munich, in September 2016. Sascha has a strong investment background with almost ten years of professional transaction and strategy experience. He has a track-record of concluding 20 M&A transactions, five of those he led as responsible project manager in his previous role as SeniorM&A Manager in a PE backed global corporation. He was a core team member in a successful EUR 2.5bn revenue cross-border merger and successfully coordinated global merger clearance procedures (USA, China, EU, Korea).

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Wellness | 1 | 33% |
| Hospitality | 1 | 33% |
| Medical Device | 1 | 33% |
| Nursing and Residential Care | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Funding Round | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 1 | 33% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Egg Medical | Egg Medical is a medical device company that offers EGGNEST, a passive protection designed to drastically reduce scatter radiation exposure for the entire cath lab team without disruption to workflow. It is an in integrated work platform built on a carbon fiber sled base designed to drastically reduce scatter radiation exposure without disruptingworkflow. | $14.3M |  | Mar 01, 2025 |  |
| Myo | Myo is a communication platform for the care market.they are proud to have designed a product with Myo that brings together people in care.their team is always looking for new talents who would like to work on a product for better care. | $8.6M | Series A | Jan 31, 2024 |  |
| Egg Medical | Egg Medical is a medical device company that offers EGGNEST, a passive protection designed to drastically reduce scatter radiation exposure for the entire cath lab team without disruption to workflow. It is an in integrated work platform built on a carbon fiber sled base designed to drastically reduce scatter radiation exposure without disruptingworkflow. | $13M | Venture - Series Unknown | Feb 26, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Agaplesion](https://shizune.co/investors/profile/agaplesion) — VC Fund, 1 deal together
- [Axel Springer Plug and Play Accelerator](https://shizune.co/investors/profile/axel-springer-plug-and-play-accelerator) — VC Fund, 1 deal together
- [BONVENTURE](https://shizune.co/investors/profile/bonventure) — VC Fund, 1 deal together
- [Capacura](https://shizune.co/investors/profile/capacura) — VC Fund, 1 deal together
- [Carpediem Capital](https://shizune.co/investors/profile/carpediem-capital-partners) — VC Fund, 1 deal together
- [Mountain Partners](https://shizune.co/investors/profile/mountain-partners) — VC Fund, 1 deal together

## About TVM Capital Life Science

VC Fund · Munich, Germany

TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Over several fund generations, their investment strategy has included a multi-stage investment approach spanningdiscovery to market ready companies as well as profitable companies searching for growth capital. Their investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. They invest in Canada, the U.S., Germany and Western Europe with their dedicated team of investment professionals based in Montreal and Munich.

5 contacts available at TVM Capital Life Science.

| Name | Title | Profile |
| --- | --- | --- |
| Catello Somma | Associate | https://shizune.co/investors/profile/catello-somma |
| Hubert Birner | Managing Partner | https://shizune.co/investors/profile/hubert-birner |
| Luc Marengere | Managing Partner | https://shizune.co/investors/profile/luc-marengere |
| Marc Riviere | General Partner | https://shizune.co/investors/profile/marc-rivi%C3%A8re |
| Sascha Berger | Partner | https://shizune.co/investors/profile/sascha-berger |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Sascha Berger invest in?

Sascha Berger invests primarily in Health Care, Wellness and Hospitality startups, most often at Series A and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sascha Berger last invest?

The most recent investment recorded for Sascha Berger closed in Mar 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co